公司资料
Atossa Therapeutics, Inc. 股价、新闻与催化剂
- 股票代码:
- ATOS
- 交易所:
- NASDAQ
- 行业:
- MedTech
- 所在地:
- United States
股票表现
2.40 USD (-0.83%)
收盘价
最后更新: 2026年9月17日
41.8M USD
市值
股价为何变动
截至 2026年9月17日，ATOS 下跌 0.83%，收于 $2.40。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
Atossa Therapeutics is a breast-cancer company focused on therapies and diagnostics in oncology and women’s health. Its business is centered on targeted disease biology and cancer-related development.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Atossa sits in specialty oncology biotechnology.
商业模式特征
The company depends on clinical data, biomarker strategy, and the ability to create a focused breast-cancer story.
生物医药行业定位
Atossa is a catalyst-sensitive oncology name whose valuation is driven by data and differentiation.
未来催化剂
- Atossa’s catalysts are endoxifen and any breast-cancer development progress that keeps the selective-estrogen-receptor story alive. The next update matters because the company still needs stronger human evidence.
近期新闻
新闻标题由机器翻译，详情为英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。